Global Prostate Cancer Treatment Drugs Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 135

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

Over the next five years, LPI(LP Information) projects that Prostate Cancer Treatment Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Prostate Cancer Treatment Drugs market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Treatment Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Enzalutamid

- Abiraterone

- Leuprolide

- Goserelin

- Triptorelin

- Histrelin

- Degarelix

- Sipuleucel-T

- Docetaxel

Segmentation by application:

- Hospital

- Research Institution

- Clinic

- Drugstore

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Tolmar

- Astellas Pharma

- AstraZeneca

- Ferring Pharmaceuticals

- Johnson & Johnson

- Abbott

- Sanofi

- Ipsen

- Novartis

- Bayer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Prostate Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Prostate Cancer Treatment Drugs market by identifying its various subsegments.

- Focuses on the key global Prostate Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Prostate Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Prostate Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Prostate Cancer Treatment Drugs Market Growth 2018-2023

Table of Contents

2018-2023 Global Prostate Cancer Treatment Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Treatment Drugs Consumption 2013-2023
2.1.2 Prostate Cancer Treatment Drugs Consumption CAGR by Region
2.2 Prostate Cancer Treatment Drugs Segment by Type
2.2.1 Enzalutamid
2.2.2 Abiraterone
2.2.3 Leuprolide
2.2.4 Goserelin
2.2.5 Triptorelin
2.2.6 Histrelin
2.2.7 Degarelix
2.2.8 Sipuleucel-T
2.2.9 Docetaxel
2.2.10 Cabazitaxel
2.3 Prostate Cancer Treatment Drugs Consumption by Type
2.3.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)
2.4 Prostate Cancer Treatment Drugs Segment by Application
2.4.1 Hospital
2.4.2 Research Institution
2.4.3 Clinic
2.4.4 Drugstore
2.5 Prostate Cancer Treatment Drugs Consumption by Application
2.5.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Prostate Cancer Treatment Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)

3 Global Prostate Cancer Treatment Drugs by Players
3.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Players
3.1.1 Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018)
3.1.2 Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)
3.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players
3.2.1 Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018)
3.2.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Prostate Cancer Treatment Drugs Sale Price by Players
3.4 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Prostate Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Prostate Cancer Treatment Drugs by Regions
4.1 Prostate Cancer Treatment Drugs by Regions
4.1.1 Global Prostate Cancer Treatment Drugs Consumption by Regions
4.1.2 Global Prostate Cancer Treatment Drugs Value by Regions
4.2 Americas Prostate Cancer Treatment Drugs Consumption Growth
4.3 APAC Prostate Cancer Treatment Drugs Consumption Growth
4.4 Europe Prostate Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Prostate Cancer Treatment Drugs Consumption Growth

5 Americas
5.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries
5.1.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
5.2 Americas Prostate Cancer Treatment Drugs Consumption by Type
5.3 Americas Prostate Cancer Treatment Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries
6.1.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
6.2 APAC Prostate Cancer Treatment Drugs Consumption by Type
6.3 APAC Prostate Cancer Treatment Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Prostate Cancer Treatment Drugs by Countries
7.1.1 Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
7.2 Europe Prostate Cancer Treatment Drugs Consumption by Type
7.3 Europe Prostate Cancer Treatment Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Treatment Drugs by Countries
8.1.1 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type
8.3 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Prostate Cancer Treatment Drugs Distributors
10.3 Prostate Cancer Treatment Drugs Customer

11 Global Prostate Cancer Treatment Drugs Market Forecast
11.1 Global Prostate Cancer Treatment Drugs Consumption Forecast (2018-2023)
11.2 Global Prostate Cancer Treatment Drugs Forecast by Regions
11.2.1 Global Prostate Cancer Treatment Drugs Forecast by Regions (2018-2023)
11.2.2 Global Prostate Cancer Treatment Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Treatment Drugs Forecast by Type
11.8 Global Prostate Cancer Treatment Drugs Forecast by Application

12 Key Players Analysis
12.1 Tolmar
12.1.1 Company Details
12.1.2 Prostate Cancer Treatment Drugs Product Offered
12.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Tolmar News
12.2 Astellas Pharma
12.2.1 Company Details
12.2.2 Prostate Cancer Treatment Drugs Product Offered
12.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Astellas Pharma News
12.3 AstraZeneca
12.3.1 Company Details
12.3.2 Prostate Cancer Treatment Drugs Product Offered
12.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 AstraZeneca News
12.4 Ferring Pharmaceuticals
12.4.1 Company Details
12.4.2 Prostate Cancer Treatment Drugs Product Offered
12.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Ferring Pharmaceuticals News
12.5 Johnson & Johnson
12.5.1 Company Details
12.5.2 Prostate Cancer Treatment Drugs Product Offered
12.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson News
12.6 Abbott
12.6.1 Company Details
12.6.2 Prostate Cancer Treatment Drugs Product Offered
12.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Abbott News
12.7 Sanofi
12.7.1 Company Details
12.7.2 Prostate Cancer Treatment Drugs Product Offered
12.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Sanofi News
12.8 Ipsen
12.8.1 Company Details
12.8.2 Prostate Cancer Treatment Drugs Product Offered
12.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Ipsen News
12.9 Novartis
12.9.1 Company Details
12.9.2 Prostate Cancer Treatment Drugs Product Offered
12.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Novartis News
12.10 Bayer
12.10.1 Company Details
12.10.2 Prostate Cancer Treatment Drugs Product Offered
12.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Bayer News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Prostate Cancer Treatment Drugs
Table Product Specifications of Prostate Cancer Treatment Drugs
Figure Prostate Cancer Treatment Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate 2013-2023 (MT)
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Prostate Cancer Treatment Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Enzalutamid
Table Major Players of Enzalutamid
Figure Product Picture of Abiraterone
Table Major Players of Abiraterone
Figure Product Picture of Leuprolide
Table Major Players of Leuprolide
Figure Product Picture of Goserelin
Table Major Players of Goserelin
Figure Product Picture of Triptorelin
Table Major Players of Triptorelin
Figure Product Picture of Histrelin
Table Major Players of Histrelin
Figure Product Picture of Degarelix
Table Major Players of Degarelix
Figure Product Picture of Sipuleucel-T
Table Major Players of Sipuleucel-T
Figure Product Picture of Docetaxel
Table Major Players of Docetaxel
Figure Product Picture of Cabazitaxel
Table Major Players of Cabazitaxel
Table Global Consumption Sales by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2013-2018) ($ million)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)
Figure Prostate Cancer Treatment Drugs Consumed in Hospital
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Research Institution
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) ($ Millions)
Figure Global Research Institution YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Clinic
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Drugstore
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) ($ Millions)
Figure Global Drugstore YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Value by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018) (MT)
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2016
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2017
Table Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2016
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2017
Table Global Prostate Cancer Treatment Drugs Sale Price by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Sale Price by Players in 2017
Table Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Prostate Cancer Treatment Drugs Products Offered
Table Prostate Cancer Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Prostate Cancer Treatment Drugs Consumption by Regions 2013-2018 (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018
Table Global Prostate Cancer Treatment Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018
Figure Americas Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Americas Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure APAC Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure APAC Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure Europe Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Europe Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Table Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Americas Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Americas Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure United States Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure United States Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Canada Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Mexico Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table APAC Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table APAC Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure China Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure China Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Japan Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Korea Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Southeast Asia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure India Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure India Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Australia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Europe Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Europe Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure Germany Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Germany Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure France Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure France Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure UK Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Italy Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Russia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Spain Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure Egypt Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Egypt Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure South Africa Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Israel Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Turkey Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure GCC Countries Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Prostate Cancer Treatment Drugs Distributors List
Table Prostate Cancer Treatment Drugs Customer List
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate Forecast (2018-2023) (MT)
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Countries (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Forecast by Regions
Table Global Prostate Cancer Treatment Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Regions
Figure Americas Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Americas Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure APAC Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure APAC Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Europe Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Europe Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure United States Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure United States Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Canada Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Canada Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Mexico Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Mexico Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Brazil Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Brazil Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure China Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure China Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Japan Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Japan Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Korea Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Korea Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Southeast Asia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure India Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure India Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Australia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Australia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Germany Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Germany Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure France Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure France Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure UK Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure UK Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Italy Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Italy Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Russia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Russia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Spain Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Spain Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Egypt Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Egypt Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure South Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure South Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Israel Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Israel Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Turkey Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Turkey Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure GCC Countries Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Type (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Application (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Prostate Cancer Treatment Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Application (2018-2023)
Table Tolmar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tolmar Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sano
  • Global Anti-Spit up Formula Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 102
    Scope of the Report: The worldwide market for Anti-Spit up Formula is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Anti-Spit up Formula in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type......
  • Global Hydrolyzed Bovine Collagen Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 107
    Scope of the Report: The worldwide market for Hydrolyzed Bovine Collagen is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Hydrolyzed Bovine Collagen in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, r......
  • Global Alpha-lactalbumin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Oct-2019        Price: US 3480 Onwards        Pages: 106
    Scope of the Report: The worldwide market for Alpha-lactalbumin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Alpha-lactalbumin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and a......
  • Global Cell Culture Protein Surface Coatings Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Cell Culture Protein Surface Coatings market will register a 9.3% CAGR in terms of revenue, the global market size will reach US$ 201.8 million by 2024, from US$ 141.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cell Culture Protein Surface Coatings business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth oppo......
  • Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth (Status and Outlook) 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 115
    According to this study, over the next five years the Amyotrophic Lateral Sclerosis (ALS) Treatment market will register a 7.2% CAGR in terms of revenue, the global market size will reach US$ 329.1 million by 2024, from US$ 249.4 million in 2019. In particular, this report presents the global revenue market share of key companies in Amyotrophic Lateral Sclerosis (ALS) Treatment business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth o......
  • Global Mouthguard Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Mouthguard market will register a 7.2% CAGR in terms of revenue, the global market size will reach US$ 225.6 million by 2024, from US$ 171.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mouthguard business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Mouthguard market by product type, applic......
  • Global Nanoemulsions Market Growth (Status and Outlook) 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 117
    According to this study, over the next five years the Nanoemulsions market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Nanoemulsions business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Nanoemulsions market by product type, application, key ......
  • Global Parkinson Disease Drug Market Growth (Status and Outlook) 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Parkinson Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Parkinson Disease Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Parkinson Disease Drug market by prod......
  • Global Intravenous Solutions (Colloids) Market Growth 2019-2024
    Published: 22-Oct-2019        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Intravenous Solutions (Colloids) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Solutions (Colloids) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Intr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs